Ongoing developments in sporadic inclusion body myositis

Machado, Pedro M., Ahmed, Mhoriam, Brady, Stefen, Gang, Qiang, Healy, Estelle, Morrow, Jasper M., Wallace, Amanda C., Dewar, Liz, Ramdharry, Gita, Parton, Matthew, Holton, Janice L., Houlden, Henry, Greensmith, Linda and Hanna, Michael G. (2014) Ongoing developments in sporadic inclusion body myositis. Current Rheumatology Reports, 16(477), ISSN (print) 1523-3774

Full text available as:
Ramdharry-G-29687.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview


Sporadic inclusion body myositis (IBM) is an acquired muscle disorder associated with ageing, for which there is no effective treatment. Ongoing developments include: genetic studies that may provide insights regarding the pathogenesis of IBM, improved histopathological markers, the description of a new IBM autoantibody, scrutiny of the diagnostic utility of clinical features and biomarkers, the refinement of diagnostic criteria, the emerging use of MRI as a diagnostic and monitoring tool, and new pathogenic insights that have led to novel therapeutic approaches being trialled for IBM, including treatments with the objective of restoring protein homeostasis and myostatin blockers. The effect of exercise in IBM continues to be investigated. However, despite these ongoing developments, the aetiopathogenesis of IBM remains uncertain. A translational and multidisciplinary collaborative approach is critical to improve the diagnosis, treatment, and care of patients with IBM.

Item Type: Article
Research Area: Allied health professions and studies
Faculty, School or Research Centre: Faculty of Health, Social Care and Education (until 2017)
Related URLs:
Depositing User: Gita Ramdharry
Date Deposited: 27 Nov 2014 09:48
Last Modified: 27 Nov 2014 09:48

Actions (Repository Editors)

Item Control Page Item Control Page